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Aims Multislice spiral computed tomography (MSCT) is a promising non-invasive method to diagnose cor-
onary artery disease (CAD). As no detailed comparative evaluation in consecutive patients referred for
evaluation of CAD has been reported, this prospective study evaluating 2384 coronary segments in 149
consecutive patients was performed.
Methods and results The coronary artery tree was analysed in 16 segments both for coronary angiogra-
phy (CA) and MSCT; a luminal narrowing 50% based on visual assessment was considered signiﬁcant. By
MSCT, 77% of 2110 angiographically assessable segments could be evaluated, 94% per patient in proximal
and 70% in distal segments (P, 0.001). Sensitivity of MSCT to detect signiﬁcant stenoses was 30% in all,
but only 10% in peripheral segments. The main limitations were calciﬁcations in 34% of segments and
motion artefacts in 24% of patients. Overall diagnostic sensitivity for the presence of signiﬁcant CAD
was 86% but speciﬁcity was only 49%.
Conclusion When compared with invasive CA, 16-slice MSCT is of limited diagnostic value for the diag-
nosis of CAD in consecutive patients. Despite a clinically useful sensitivity for the overall diagnosis of
signiﬁcant CAD, speciﬁcity is low. Thus, relevant decisions regarding the need of and suitability for poss-








Invasive coronary angiography (CA) is the current gold-
standard for the assessment of coronary anatomy and diag-
nosis of coronary artery disease (CAD) with a low but deﬁnite
complication rate.1 Multislice spiral computed tomography
(MSCT) CA is a promising non-invasive technique for the
detection of CAD. To make MSCT a clinically useful tool for
the evaluation of patients with suspected or known CAD,
complete visualization of all clinically relevant segments
of coronary arteries and a reliable quantiﬁcation of coronary
artery stenoses within these segments are mandatory. This
is particularly true if revascularization procedures such as
coronary angioplasty or bypass surgery are also to be
planned on the basis of MSCT ﬁndings. Previous studies
with relatively small numbers of selected patients reported
a high sensitivity and speciﬁcity for the detection of signiﬁ-
cant obstructive coronary lesions.2–6 In a recently published
study, 16-slice MSCTwas shown to reliably detect signiﬁcant
obstructive CAD in patients with stable angina in sinus
rhythm, with a high negative predictive value (NPV) and a
lower sensitivity for the detection of non-calciﬁed lesions.7
However, no prospective series of unselected patients
referred for the evaluation of suspected or known CAD in
view of further therapeutic interventions have been studied
or reported. Therefore, we set out to test the diagnostic
yield of 16-slice MSCT in the routine work-up of consecutive
patients referred for conventional X-ray CA for the evaluation




In this prospective study, 149 consecutive patients referred for
elective invasive evaluation of known or suspected CAD
were included between November 2002 and September 2003.
Exclusion criteria were women in childbearing age, known hypersen-
sitivity against iodine-based contrast agents, serum creatinine
.130 mmol/L, fasting serum glucose .13 mmol/L, and no
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consent. All patients were studied on their prescribed medication
and, in fact, 69% were taking beta-blocking drugs. The study proto-
col was approved by the Ethics Committee of the states of Basel
according to the Helsinki Declaration (1975/1983), and all patients
gave written informed consent.
Procedures
Diagnostic invasive CA was performed according to standard Judkins
procedure using 6F catheters the day following MSCT. MSCT data
were acquired using a 16-slice scanner (Sensation 16, Siemens
Medical Systems, Forchheim, Germany). To calculate the bolus
arrival time for the contrast-enhanced scan, 20 mL of contrast
media were injected at a rate of 4 mL/s with a power injector
(Ulrich, Ulm, Germany), 300 mg iodine/mL (Ultravist 300,
Schering, Germany), followed by a chaser bolus of 20 mL saline in
the antecubital vein. CT attenuation values were measured at the
level of the ascending aorta to identify the ﬁrst slice with an opaci-
ﬁcation of 100 HE and to calculate the scan delay time.
Subsequently, the contrast media bolus was injected (80 mL at the
rate of 4 mL/s followed by a saline chaser of 20 mL at the rate of
4 mL/s). A contrast-enhanced retrospectively ECG-gated scan
(16  0.75 mm collimation, table feed 2.8 mm/rotation, effective
tube current 400 mA at 120 kV) was acquired. A typical scan
length was 25 s. No additional beta-blocker was administered to
modulate heart rate. Images were reconstructed with the multiseg-
ment algorithm with retrospective ECG gating. Reconstruction
started at 2600, 2500, 2400, and 2300 ms. Images were recon-
structed with 1 mm slice thickness and 0.5 mm increment to
obtain isotropic voxels of 1  1  1 mm3. For analysis, the reviewers
were allowed to choose the data set with the fewest artefacts.
Analysis of data
All angiograms were analysed post hoc by an experienced interven-
tional cardiologist. MSCT images were analysed by an experienced
radiologist and an experienced cardiologist in consensus, the
latter being experienced in interventional cardiology. Data sets
were reviewed ofﬂine at a workstation (Leonardo, Siemens,
Germany). Reading physicians were blinded to invasive CA results
and were allowed to use axial source images at all reconstructed
phases, as well as to reconstruct these 3D data sets in multiplanar
mode. For the analysis of MSCT and CA, the coronary artery tree
was broken down in 16 segments after a modiﬁed American Heart
Association (AHA) classiﬁcation (Figure 1 )8 and all segments were
analysed individually. A luminal narrowing of .50% based on
visual estimation was considered signiﬁcant in both modalities.
Three typical examples of corresponding views by CA and MSCT
are shown in Figure 2.
Statistical analysis
Data are expressed as frequencies, mean+ standard deviation, or
median (interquartile range) as appropriate. Kolmogorov–Smirnov
test was used to test categorical and continuous variables for
normal distribution. If not normally distributed, non-parametric
tests were used and data are expressed as median (adjusted for
group mid-points) and interquartile range. Categorical variables
were compared using x2 and Fisher’s exact test or Yates’ corrected
x2 as appropriate. Receiver–operator characteristics curve was used
to test sensitivity and speciﬁcity to diagnose signiﬁcant CAD
by number of positive segments in MSCT. For the analysis of the
diagnostic accuracy of MSCT per coronary artery segments, only
segments which could be adequately assessed by CA were con-
sidered. Only descriptive data are provided for segments because
of potential within patient correlations. All calculations were
Figure 1 Segmental anatomy of the coronary arteries after a modiﬁed AHA
classiﬁcation. 1, RCA proximal; 2, RCA mid; 3, RCA distal; 4, right posterior
descendens; 5, main stem; 6, LAD proximal; 7, LAD mid; 8, LAD distal; 9,
ﬁrst diagonal; 10, second diagonal; 11, LXC proximal; 12, obtuse marginal;
13, LCX distal; 14, LCX posterolateral branch; 15, LCX posterodescendens
branch; 16, RCA posterolateral branch. RCA, right coronary artery; LCX,
left circumﬂex artery; LAD, left anterior descending coronary artery.
Figure 2 Typical examples of corresponding views by CA (left) and MSCT
(right). (A ) True-positive MSCT with high-grade stenosis (arrows) of segment
1 visible by both CA and MSCT. (B ) False-negative MSCT with high-grade
eccentric web-shaped stenosis of segment 2 (arrow), clearly visible by CA
but not visible by MSCT. (C ) False-positive MSCT with normal CA of RCA.
MSCT shows a lesion in segment 2 (arrow), which was interpreted as signiﬁ-
cant stenosis.
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done with the use of a commercially available statistical program
(SPSS v 12 for Windows). Two-sided tests were used. A P-value
of ,0.05 was considered statistically signiﬁcant. Bonferroni adjust-
ment was made for comparison of per cent of assessable segments in
the three main vessels of each patient.
Showing a signiﬁcant relationship between stenoses seen by MSCT
and CA would have needed a substantially smaller number of
patients. However, we aimed to compare the two methods in a clini-
cally meaningful number of patients. Hence, we included approxi-
mately 150 patients, which is comparable with previous studies
addressing this and other comparable issues.
Results
Patients’ characteristics are depicted in Table 1. The CA
revealed CAD in 113 (76%) patients (one-vessel disease
n ¼ 25; two-vessel disease n ¼ 38; three-vessel disease
n ¼ 50), whereas 36 patients had no signiﬁcant coronary
obstructions (severe mitral or aortic valve disease n ¼ 9; car-
diomyopathy n ¼ 8; hypertensive heart disease n ¼ 2; no
discernible heart disease n ¼ 17).
Visibility and evaluability of coronary artery
segments by MSCT vs. CA
Of a total of 2384 coronary artery segments, 2110 (89%)
were visible by CA. Of these, 1854 (88%) were visible and
1619 (77%) could be assessed by MSCT [median per patient
80% (interquartile range 28%)]. Factors independently inﬂu-
encing the per cent of assessable segment per patient were
motion artefacts (P  0.0001) and per cent of calciﬁed seg-
ments (P  0.05). Motion artefacts were noted in 35 patients
(24%). In these patients, heart rate was signiﬁcantly higher
(72+ 13 b.p.m.): in 66% (23 of 35), heart rate was
65 b.p.m. when compared with a heart rate of 61+ 10
and in only 30% (33 of 109), heart rate was 65 b.p.m.
without motion artefacts (both P  0.001).
If the heart rate was 65 b.p.m., 248 of 797 (31%) seg-
ments were not assessable compared with 243 of 1313
(19%) segments with lower heart rate. Thus, in patients
with heart rate 65 b.p.m., a median of 71% of the seg-
ments (interquartile range 28%) were assessable vs. 86%
(interquartile range 25%) in patients with lower heart rate
(P  0.001).
Most segments were assessable in the LAD [median per
patient 88% (interquartile range 29%)], followed by the
right coronary artery (RCA) [84 (41%), P  0.01 vs. LAD],
and least in the LCX [71 (44%), P  0.01 vs. LAD and RCA].
As expected, the number of assessable segments was
larger for proximal (1,2,5,6,7,11, and 13) than for distal
segments [median of assessable segments per patient (inter-
quartile range) 94 (15%) vs. 70 (46%), P  0.001].
Heart rate signiﬁcantly inﬂuenced assessable segments
per patient in LCX, but not in LAD and RCA (Figure 3 ).
Also, proximal segments were inﬂuenced less than distal
segments by heart rate (median of assessable segments
per patient with heart rate 65 vs. .65 b.p.m.; proximal
95 vs. 91%, P ¼ 0.08; distal 77 vs. 56%, P, 0.001).
Detection of signiﬁcant stenoses by MSCT vs. CA
Binary stenoses were found by CA in 432 (20%) and by MSCT
in 274 (13%) segments. Detailed results of analyses of all seg-
ments and subdivided for the three main coronary vessels
and proximal vs. distal segments are given in Table 2. The
sensitivity of MSCT to detect signiﬁcant lesions was highest
in proximal LAD and RCA and lowest in distal segments of
three coronary arteries. In contrast, speciﬁcity was higher
in all vessels. The sensitivity of MSCT to detect proximal
lesions was markedly better than to detect distal lesions
(47 vs. 10%), but because of the lower frequency of stenoses
in the distal segments, the speciﬁcity was somewhat lower.
False-positive ﬁndings were seen more often in the pre-
sence of calciﬁcations noted by MSCT (present in 34% of
all segments). Thus, NPV was 77% in the presence of calciﬁ-
cation but 86% in the absence (speciﬁcity 75 and 98%,
respectively). In contrast, the positive predictive value
(PPV) was substantially lower if calciﬁcations were not
seen (28 vs. 50%) and sensitivity was minimal (5 vs. 52%).
Calciﬁcation per se in MSCT had a sensitivity of 52% and a
speciﬁcity of 71% (PPV: 32%, NPV: 85%) in the presence of
a signiﬁcant stenosis by CA.
Sensitivity was identical in patients with heart rate 65
when compared with 65 b.p.m. (29 vs. 30%). Speciﬁcity
(93 vs. 89%) as well as PPV (53 vs. 37%) was slightly higher,
but NPV was lower (82 vs. 86%). Diagnostic yield per
segment including only patients without motion artefacts
(n ¼ 1535) was not substantially higher (sensitivity 31%,
speciﬁcity 91%, PPV 49%, and NPV 83%).
Table 1 Baseline characteristics
Total number of patients (n ) 149
Male (%) 110 (74)
Age (years; x¯+ SD) 63.9+ 9.0
Current smoker (%) 62 (42)
Arterial hypertension (%) 94 (63)
Positive family history (%) 57 (38)
Hypercholesterolaemia (%) 96 (64)
Diabetes mellitus (%) 26 (17)
Known CAD (%) 62 (42)
Prior MI (%) 43 (29)
Prior CABG/PCI (%) 51 (34)
Typical angina CCS II 78 (52)
Atypical chest pain 31 (21)
Dyspnoea 28 (19)
Silent ischaemia 12 (8)
CABG, coronary artery bypass graft; CCS, Canadian Cardiac Society; MI,
myocardial infarction; PCI, percutaneous coronary intervention.
Figure 3 Per cent of assessable segments per patient in the three main cor-
onary arteries subdivided in patients with heart rate above and below
65 b.p.m.
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A total of 45 segments (2.1%) were previously stented;
diagnostic accuracy was lower in these segments (58%).
However, excluding these segments from analysis did not
inﬂuence the overall results at all (diagnostic accuracy 79%
irrespective of inclusion or exclusion of these segments).
Diagnosing CAD
CAD with at least one coronary stenosis .50% was
diagnosed in 113 (76%) patients by CA and in 115 (77%) by
MSCT. Overall, the identiﬁcation of patients with CAD by
MSCT was reasonably good; the results of exclusion of rel-
evant disease were however poor (Figure 3 ). Considering
all the three individual vessels, the diagnosis of signiﬁcant
disease by MSCT was most difﬁcult in the LCX (Figure 4 ).
When considering only proximal stenoses [present in 101
patients (68%)], diagnostic yield was basically identical
(Figure 5 ). In particular, the speciﬁcity remained low. Both
the number of segments with stenosis and the calciﬁcation
in MSCT were signiﬁcantly related to the diagnosis of CAD
by CA (P  0.001), but area under curve in ROC analysis
was relatively low (both 0.78+ 0.04).
In patients with heart rate 65 b.p.m., sensitivity was
identical (86 vs. 86%), but speciﬁcity was slightly higher,
though still insufﬁcient (59 vs. 40%; PPV 90 vs. 72%, NPV
48 vs. 62%, diagnostic accuracy 81 vs. 70%). The inﬂuence
of heart rate on diagnostic yield was not statistically signiﬁ-
cant, neither overall nor in one of the three main coronary
Table 2 Diagnosis of signiﬁcant stenosis by MSCT in all segments and subdivided in the three main vessels and in proximal and distal
segment
n TP TN FP FN Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
All segments 2110 128 1532 146 304 30 91 47 83
LM 145 4 122 8 11 27 94 33 92
LAD 684 58 439 70 117 33 86 45 79
Proximal 147 23 76 33 15 61 70 41 84
Middle 142 24 68 19 31 44 78 56 69
Distal 141 7 108 9 17 29 92 44 86
Diagonal 1 138 4 88 9 37 10 91 31 70
Diagonal 2 116 0 99 0 17 0 100 0 85
LCX 630 19 483 27 101 16 95 41 83
Proximal 145 12 104 13 16 43 89 48 87
Middle 104 5 80 7 12 29 92 42 87
Distal 110 0 91 0 19 0 100 0 83
Marginal 1 142 1 95 7 39 3 93 13 71
Marginal 2 129 1 113 0 15 6 100 100 88
RCA 651 47 488 41 75 39 92 53 87
Proximal 148 21 100 13 14 60 89 62 88
Middle 134 19 73 20 22 46 79 49 77
Distal 123 5 97 4 17 23 96 56 85
RPD 124 0 111 1 12 0 99 0 90
RPL 122 2 107 3 10 17 97 40 92
Proximala 965 108 623 113 121 47 85 49 84
Distal 1145 20 909 33 183 10 97 38 83
aproximal segments: 1,2,5,6,7,11, and 13.
LM, left main coronary artery, RPD, right posterior descending; PRL, right posterolateral branch; TP, true positive; TN, true negative; FP, false positive; FN,
false negative.
Figure 4 Diagnostic accuracy of MSCT for the detection of CAD in each
patient compared with CA. Sens., sensitivity; Spec., speciﬁcity; PPV, positive
predictive value; NPV, negative predictive value; DA, diagnostic accuracy.
Figure 5 Diagnostic accuracy of MSCT for the detection of CAD in proximal
coronary arteries only compared with CA (abbreviations see Figure 4 ).
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arteries. The absence of motion artefacts tended to improve
the diagnostic yield. Again, it remained clinically insufﬁcient
(sensitivity 87 vs. 82%, speciﬁcity 50 vs. 46%, PPV 86 vs. 72%,
NPV 52 vs. 60%, diagnostic accuracy 79 vs. 69%).
In various subgroups of patients with lower probability of
CAD, diagnostic yield was not substantially different in the
whole group (Table 3 ).
Discussion
The most important ﬁnding of the study of MSCT in consecu-
tive patients referred for the evaluation of CAD by CA is that
MSCT yields reasonable sensitivity but low speciﬁcity for the
diagnosis/exclusion of signiﬁcant CAD. The main reasons for
these limitations are the high rate of calciﬁcations in such
patients, which may mask or exist without relevant coronary
lesions, and the high susceptibility of the method to motion
artefacts. In addition, MSCT is limited in deﬁning involved
coronary segments. Particularly, distal segments and those
of the LCX are not sufﬁciently well detected. Therefore,
present-day 16-slice MSCT is of limited value for detailed
analysis of the extent of CAD in view of need of and suit-
ability for possible revascularization procedures in patients
referred for the evaluation of CAD. The emerging 64-slice
technology will provide better spatial and temporal reso-
lution combined with faster acquisition times and therefore
potentially improve diagnostic accuracy in calciﬁed and
peripheral segments.
Diagnosis of CAD
For the individual patient, a correct diagnosis or exclusion of
signiﬁcant CAD is most important. Kuettner et al.9 reported
a correct diagnosis by MSCT in only 35% of all their patients.
In the present study of unselected patients with a relatively
high pre-test probability of CAD, an overall accuracy of 77%
was found in the correct diagnosis of relevant CAD by MSCT.
Considering the high rate of coronary risk factors and high
prevalence of CAD in referral patients, a high sensitivity as
reported here may be expected. The low speciﬁcity with
many false-positive results was most likely due to the
more frequent occurrence of calciﬁcations in elderly and
high-risk patients, which may lead to misinterpretations.10
Again, sensitivity remained particularly low in the LCX.
Taking into account only proximal stenoses, diagnostic
yield did not improve substantially, indicating that the
rate of false-positive results remains unchanged compared
with smaller peripheral segments. Comparing the results
of the present study with other non-invasive tests for the
detection of CAD as recently reported in a large pooled
analysis,11 the sensitivity of MSCT may be even somewhat
better than that of myocardial perfusion scintigraphy (79%)
and stress echocardiography (76%), with, however, a mark-
edly inferior speciﬁcity of 49% compared with 73% for
scintigraphy and 88% for stress echocardiography. The diag-
nostic yield of MSCT improved to a certain extent in patients
with low heart rates 65 b.p.m. and in patients with
absence of motion artefacts. However, the overall NPV for
MSCT also in these subgroups of patients limits this method
as a screening tool for the exclusion of signiﬁcant CAD.
Visibility and evaluability of coronary
artery segments
Early studies in selected patients reported up to 94% of
coronary segments evaluable by MSCT,5 whereas in the
present study, only 77% of all angiographically visible
segments were evaluable by MSCT. Evaluability was
particularly impaired in peripheral segments. Similar ﬁnd-
ings have been reported by Gerber, Nieman, Achenbach,
and others,2,3,9,12–15 who also included peripheral segments
and side branches in their analyses as done in the present
study. The most important reasons for impaired visibility
and evaluability of coronary artery segments by MSCT may
be motion artefacts, calciﬁcations, and the presence of cor-
onary stents.4,9,13 In the present study of unselected
patients, these factors only partly explained the relatively
low diagnostic yield of MSCT.
Furthermore, the inﬂuence of heart rate on the image
quality of MSCT has been well described.2,9,14,16 Schroeder
et al.14 suggested to lower the heart rate 65 b.p.m. to
achieve best image quality. As half of our patients had
known or suspected LAD, 69% were already treated with
oral beta-blockers, resulting in a low mean heart rate of
63 b.p.m. during MSCTwithout additional i.v. beta-blockade.
According to the ﬁndings by Gerber et al.12 patients with
heart rates.65 b.p.m. showed a higher rate of motion arte-
facts, resulting in a lower rate of visible and evaluable cor-
onary artery segments by MSCT, which is conﬁrmed in this
study. In most of the published studies,2,4,5 evaluability
was particularly poor in coronary segments of the lateral
wall because of the fact that the LCX easily blends with
adjacent contrast-ﬁlled structures such as the great
cardiac vein and the left atrium. This is also reﬂected in
the present study by signiﬁcantly impaired visibility and eva-
luability of the LCX when compared with the other two main
Table 3 Diagnostic accuracy of diagnosing CAD in different subgroups of patients
Overall No typical angina Risk factors 0–2a Age ,65 years
Number of patients (% of all patients) 149 (100) 72 (48) 62 (42) 78 (52)
Patients with stenosis by CA (%) 113 (76) 45 (63) 39 (63) 56 (72)
Sensitivity (%) 86 89 79 79
Speciﬁcity (%) 49 52 57 50
Positive predictive value (%) 84 76 76 80
Negative predictive value (%) 53 74 62 48
Diagnostic accuracy (%) 77 75 71 71
CA, coronary angiography.
aPatients with a maximum of two cardiovascular risk factors (hypercholesterolaemia, arterial hypertension, current smoking, diabetes mellitus, and family
history).
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coronary artery vessels, especially in patients with heart
rates .65 b.p.m.
Detection of stenoses
The overall diagnostic yield of MSCT in each angiographically
assessable segment in the present report is similar to
that reported by Kuettner et al.9 and Nieman et al.17 but
inferior to that published by other groups.2,3,5,7,13,15 The
main reasons for these discrepancies are that most of
those studies included highly selected patients and that
for their analyses, peripheral segments were excluded or
combined. In contrast to proximal vessels, MSCT yields a
very poor sensitivity in the periphery of the coronary
arteries. We could also conﬁrm the limitations of MSCT in
the lateral wall with a low sensitivity in the LCX. It is
known that coronary calciﬁcations are associated with the
presence of signiﬁcant coronary stenoses.10 This was true
in the present report in 32% of calciﬁcations. However, cal-
ciﬁcations were also noted in 68% of segments in MSCT
without signiﬁcant stenoses. In non-calciﬁed segments,
however, the sensitivity of MSCT even dropped to an
overall of 5% because of the low tissue contrast, particularly
in small non-calciﬁed segments.
Limitations
There are some limitations to the present study. Hence, we
included only patients with relatively high probability of
CAD in our study. MSCT might be contemplated in the pre-
sence of an intermediate likelihood of signiﬁcant CAD and
ambiguous prior test results. This, however, has not yet
been investigated. We did not ﬁnd any subgroup where
MSCT yielded sufﬁcient diagnostic accuracy. This also
applies to subgroups with lower probability of CAD, such as
patients with non-typical symptoms or limited number of
cardiovascular risk factors, tempering the enthusiasm of
using MSCT as a broad screening tool for CAD.
In some of our patients, heart rate was above the
suggested limit of 65 b.p.m., resulting in a higher rate of
motion artefacts and a somewhat lower diagnostic yield of
MSCT. However, MSCT did not provide sufﬁciently high diag-
nostic accuracy, even after exclusion of patients with heart
rate .65 b.p.m. from analysis. In particular, NPV was rela-
tively low, thereby limiting the value of MSCT as a tool to
exclude CAD. Routine administration of additional i.v.
beta-blockers to every patient may have improved the
image quality in some of the patients.
Moreover, the time points for image reconstruction in
MSCT with 100 ms steps was rather crude; steps of 50 ms
may be favourable to optimize the analysis.
Conclusions
When compared with gold-standard CA, 16-slice MSCT is of
limited diagnostic value for the detailed diagnosis of CAD
in non-selected patients with moderate-to-high probability
of CAD. Despite a reasonable sensitivity for the overall
diagnosis of ‘signiﬁcant CAD’, speciﬁcity is low and lesions
in distal segments and those of the LCX coronary artery
are not sufﬁciently well detected. Factors limiting MSCT
are poor visibility and evaluability of peripheral segments,
misinterpretation of calciﬁed segments, and a very low diag-
nostic accuracy in non-calciﬁed vessels.
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